Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2

被引:0
|
作者
Yu Mi Oh
Hyung Bae Park
Jae Hun Shin
Ji Eun Lee
Ha Young Park
Dhong Hyo Kho
Jun Sung Lee
Heonsik Choi
Tomohiko Okuda
Koichi Kokame
Toshiyuki Miyata
In-Hoo Kim
Seung Hoon Lee
Ronald H. Schwartz
Kyungho Choi
机构
[1] Seoul National University College of Medicine,Department of Biochemistry and Molecular Biology
[2] Seoul National University College of Medicine,Department of Biomedical Sciences
[3] 103 Daehak-ro,Department of Molecular Pathogenesis
[4] Chongno-gu,undefined
[5] Seoul 110-799,undefined
[6] Korea,undefined
[7] Specific Organs Cancer Branch,undefined
[8] Research Institute National Cancer Center,undefined
[9] Hematologic Malignancy Branch,undefined
[10] Research Institute National Cancer Center,undefined
[11] Laboratory of Cellular and Molecular Immunology,undefined
[12] National Institute of Allergy and Infectious Diseases,undefined
[13] National Institutes of Health,undefined
[14] National Cerebral and Cardiovascular Center,undefined
[15] Molecular Imaging and Therapy Branch,undefined
[16] Research Institute National Cancer Center,undefined
[17] Present address: Department of Immunobiology,undefined
[18] Yale University School of Medicine,undefined
[19] New Haven,undefined
[20] Connecticut 06520,undefined
[21] USA.,undefined
[22] Present address: Department of Pathology and Oncology,undefined
[23] Karmanos Cancer Institute,undefined
[24] Wayne State University School of Medicine,undefined
[25] Detroit,undefined
[26] Michigan 48201,undefined
[27] USA.,undefined
[28] Present address: Green Cross Corporation,undefined
[29] Gyeonggi-Do 446-850,undefined
[30] Korea.,undefined
[31] Present address: Kolon life science inc.,undefined
[32] Seoul 153-769,undefined
[33] Korea.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Induction of T-cell clonal anergy involves serial activation of transcription factors, including NFAT and Egr2/3. However, downstream effector mechanisms of these transcription factors are not fully understood yet. Here we identify Ndrg1 as an anergy factor induced by Egr2. Ndrg1 is upregulated by anergic signalling and maintained at high levels in resting anergic T cells. Overexpression of Ndrg1 mimics the anergic state and knockout of the gene prevents anergy induction. Interestingly, Ndrg1 is phosphorylated and degraded by CD28 signalling in a proteasome-dependent manner, explaining the costimulation dependence of anergy prevention. Similarly, IL-2 treatment of anergic T cells, under conditions that lead to the reversal of anergy, also induces Ndrg1 phosphorylation and degradation. Finally, older Ndrg1-deficient mice show T-cell hyperresponsiveness and Ndrg1-deficient T cells aggravate inducible autoimmune inflammation. Thus, Ndrg1 contributes to the maintenance of clonal anergy and inhibition of T-cell-mediated inflammation.
引用
收藏
相关论文
共 50 条
  • [21] T-CELL PROLIFERATION INVOLVING THE CD28 PATHWAY IS ASSOCIATED WITH CYCLOSPORINE-RESISTANT INTERLEUKIN-2 GENE-EXPRESSION
    JUNE, CH
    LEDBETTER, JA
    GILLESPIE, MM
    LINDSTEN, T
    THOMPSON, CB
    MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (12) : 4472 - 4481
  • [22] Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation
    Dafni A. Glinos
    Blagoje Soskic
    Cayman Williams
    Alan Kennedy
    Luke Jostins
    David M. Sansom
    Gosia Trynka
    Genes & Immunity, 2020, 21 : 390 - 408
  • [23] Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation
    Glinos, Dafni A.
    Soskic, Blagoje
    Williams, Cayman
    Kennedy, Alan
    Jostins, Luke
    Sansom, David M.
    Trynka, Gosia
    GENES AND IMMUNITY, 2020, 21 (6-8) : 390 - 408
  • [24] T-CELL GROWTH-FACTOR (INTERLEUKIN-2)
    ALTMAN, A
    IMMUNOLOGY TODAY, 1981, 2 (01): : 1 - 3
  • [25] A NOVEL ACTIVATION PATHWAY FOR MATURE THYMOCYTES - COSTIMULATION OF CD2 (T,P50) AND CD28 (T,P44) INDUCES AUTOCRINE INTERLEUKIN-2 INTERLEUKIN-2 RECEPTOR-MEDIATED CELL-PROLIFERATION
    YANG, SY
    DENNING, SM
    MIZUNO, S
    DUPONT, B
    HAYNES, BF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (04): : 1457 - 1468
  • [26] CD28 costimulates interleukin-2 (IL-2) production independent of its tyrosine phosphorylation in a murine T-cell hybridoma.
    Nagel, T
    Shi, J
    Truitt, KE
    Imboden, JB
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1723 - 1723
  • [27] CD28 costimulation and cell cycle progression are together necessary and sufficient for anergy avoidance in primary CD4+T cells.
    Wells, AD
    Walsh, MC
    Sankaran, D
    Turka, LA
    TRANSPLANTATION, 2000, 69 (08) : S130 - S130
  • [28] Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production
    Civil, A
    Bakker, A
    Rensink, I
    Doerre, S
    Aarden, LA
    Verweij, CL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (14) : 8321 - 8327
  • [29] Regulated costimulation in the thymus is critical for T cell development: Dysregulated CD28 costimulation can bypass the pre-TCR checkpoint
    Williams, JA
    Hathcock, KS
    Klug, D
    Harada, Y
    Choudhury, B
    Allison, JP
    Abe, R
    Hodes, RJ
    JOURNAL OF IMMUNOLOGY, 2005, 175 (07): : 4199 - 4207
  • [30] EFFECTS OF COSTIMULATION OF CD28 BY ITS LIGAND B7 ON HUMAN T-CELL SUBSETS
    VANLIER, R
    KUIPER, H
    BROUWER, M
    PARREN, P
    DEBOER, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 86 - 86